These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1075 related articles for article (PubMed ID: 32676784)

  • 21. Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.
    Hectors SJ; Cherny M; Yadav KK; Beksaç AT; Thulasidass H; Lewis S; Davicioni E; Wang P; Tewari AK; Taouli B
    J Urol; 2019 Sep; 202(3):498-505. PubMed ID: 30958743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors.
    Gaudiano C; Bianchi L; De Cinque A; Corcioni B; Giunchi F; Schiavina R; Fiorentino M; Brunocilla E; Golfieri R
    Radiol Med; 2022 Feb; 127(2):174-182. PubMed ID: 34850354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
    Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
    J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature.
    Zhang L; Zhe X; Tang M; Zhang J; Ren J; Zhang X; Li L
    Contrast Media Mol Imaging; 2021; 2021():7830909. PubMed ID: 35024015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A deep dive into understanding tumor foci classification using multiparametric MRI based on convolutional neural network.
    Zong W; Lee JK; Liu C; Carver EN; Feldman AM; Janic B; Elshaikh MA; Pantelic MV; Hearshen D; Chetty IJ; Movsas B; Wen N
    Med Phys; 2020 Sep; 47(9):4077-4086. PubMed ID: 32449176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.
    Woźnicki P; Westhoff N; Huber T; Riffel P; Froelich MF; Gresser E; von Hardenberg J; Mühlberg A; Michel MS; Schoenberg SO; Nörenberg D
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins.
    He D; Wang X; Fu C; Wei X; Bao J; Ji X; Bai H; Xia W; Gao X; Huang Y; Hou J
    Cancer Imaging; 2021 Jul; 21(1):46. PubMed ID: 34225808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of prostate cancer using texture analysis for diagnostic and prognostic monitoring.
    Singh D; Kumar V; Das CJ; Singh A; Mehndiratta A
    NMR Biomed; 2021 Jun; 34(6):e4495. PubMed ID: 33638244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninferiority of Monoparametric MRI Versus Multiparametric MRI for the Detection of Prostate Cancer: Diagnostic Accuracy of ADC Ratios Based on Advanced "Zoomed" Diffusion-Weighted Imaging.
    Raczeck P; Frenzel F; Woerner T; Graeber S; Bohle RM; Ziegler G; Buecker A; Schneider GK
    Invest Radiol; 2022 Apr; 57(4):233-241. PubMed ID: 34743133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance radiomic feature performance in pulmonary nodule classification and impact of segmentation variability on radiomics.
    Koo CW; Kline TL; Yoon JH; Vercnocke AJ; Johnson MP; Suman G; Lu A; Larson NB
    Br J Radiol; 2022 Dec; 95(1140):20220230. PubMed ID: 36367095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
    Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
    Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS.
    Stavrinides V; Syer T; Hu Y; Giganti F; Freeman A; Karapanagiotis S; Bott SRJ; Brown LC; Burns-Cox N; Dudderidge TJ; Bosaily AE; Frangou E; Ghei M; Henderson A; Hindley RG; Kaplan RS; Oldroyd R; Parker C; Persad R; Rosario DJ; Shergill IS; Echeverria LMC; Norris JM; Winkler M; Barratt D; Kirkham A; Punwani S; Whitaker HC; Ahmed HU; Emberton M;
    Eur Urol; 2021 Jan; 79(1):20-29. PubMed ID: 33051065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
    Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
    Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
    Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
    J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically significant prostate cancer detection on MRI: A radiomic shape features study.
    Cuocolo R; Stanzione A; Ponsiglione A; Romeo V; Verde F; Creta M; La Rocca R; Longo N; Pace L; Imbriaco M
    Eur J Radiol; 2019 Jul; 116():144-149. PubMed ID: 31153556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine learning-based radiomics analysis in predicting the meningioma grade using multiparametric MRI.
    Hu J; Zhao Y; Li M; Liu J; Wang F; Weng Q; Wang X; Cao D
    Eur J Radiol; 2020 Oct; 131():109251. PubMed ID: 32916409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
    Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
    Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.